Home treatment of covid-19: an alternative to the hospital crisis
DOI:
https://doi.org/10.54943/rcsxxi.v1i1.5Keywords:
Coronavirus 2019-nCoV, Coronavirus 2019-nCoV infection, Public HealthAbstract
The clinical manifestations of coronavirus (Covid-19) can be variable depending on the immune status of the person. Evidence of individualized and comprehensive clinical management at home and in isolation is scarce at the national level. Two identified cases of SARS-CoV-2 infection and a positive blood test for Covid-19 are described. Of these patients, one with comorbidity characteristics; grade I obesity, the other hypercholesterolemia. The case of a 60-year-old and 59-year-old married couple with clinical pictures of coronavirus infection (Covid-19) is described, receives treatment with ivermectin, azithromycin, dexamethasone, enoxaparin, ceftriaxone, ozone, acetylcysteine, fenofibrate and oxygen therapy; observing a clinical benefit of the therapeutic combination.
Downloads
References
Albani, F., Sepe, L., Fusina, F., Prezioso, C., Baronio, M., Caminiti, F., Di Maio, A., Faggian, B., Franceschetti, M. E., Massari, M., Salvaggio, M., & Natalini, G. (2020). Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study. EClinicalMedicine, 27, 6. https://doi.org/10.1016/j.eclinm.2020.100562
Cattel, F., Giordano, S., Bertiond, C., Lupia, T., Corcione, S., Scaldaferri, M., Angelone, L., & De Rosa, F. G. (2021). Ozone therapy in COVID-19: A narrative review. Virus Research, 291, 5. https://doi.org/10.1016/j.virusres.2020.198207
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet, 395, 507-513. 10https://doi.org/10.1016/S0140-6736(20)30211-7
Cinesi Gómez, C., Peñuelas Rodríguez, Ó., Luján Torné, M., Egea Santaolalla, C., Masa Jiménez, J. F., García Fernández, J., Carratalá Perales, J. M., Heili-Frades, S. B., Ferrer Monreal, M., de Andrés Nilsson, J. M., Lista Arias, E., Sánchez Rocamora, J. L., Garrote, J. I., Zamorano Serrano, M. J., González Martínez, M., Farrero Muñoz, E., Mediano San Andrés, O., Rialp Cervera, G., Mas Serra, A., ... Ferrando Ortola, C. (2020). Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infección por SARS-CoV-2. Medicina Intensiva, 44(7), 429-438. https://doi.org/10.1016/j.medin.2020.03.005
DIRESA, Huancavelica. (2020). Reporte oficial COVID-19. https://www.diresahuancavelica.gob.pe/wp_diresa/
Gonzales-Zamora, J. A., Quiroz, T., & Vega, A. D. (2020). Tratamiento exitoso con Remdesivir y corticoides en un paciente con neumonía asociada a COVID-19: Reporte de un caso. Medwave, 20(07). https://doi.org/10.5867/medwave.2020.07.7998
Khan, Md. S. I., Khan, Md. S. I., Debnath, C. R., Nath, P. N., Mahtab, M. A., Nabeka, H., Matsuda, S., & Akbar, S. M. F. (2020). Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19. Archivos de Bronconeumología. 56(12), 828-830. https://doi.org/10.1016/j.arbres.2020.08.007
Lemos, A. C. B., do Espírito Santo, D. A., Salvetti, M. C., Gilio, R. N., Agra, L. B., Pazin-Filho, A., & Miranda, C. H. (2020). Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID). Thrombosis Research, 196, 359-366. https://doi.org/10.1016/j.thromres.2020.09.026
MINSA. (2020). Covid 19 en el Perú. https://covid19.minsa.gob.pe/sala_situacional.asp
Minsalud, Colombia. (2020). Lineamientos para la evaluación del riesgo y el tratamiento domiciliario, según la valoración médica así lo determine, en pacientes con sospecha o confirmación de infección por Sars-CoV-2/Covid-19. https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/MET/gmtl01-lineamiento-evaluacion-riesgo-valoracion-med-covid-19.pdf
Rajter, J. C., Sherman, M. S., Fatteh, N., Vogel, F., Sacks, J., & Rajter, J.-J. (2020). Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The ICON Study. Chest. https://doi.org/10.1016/j.chest.2020.10.009
Sekhavati, E., Jafari, F., SeyedAlinaghi, S., Jamalimoghadamsiahkali, S., Sadr, S., Tabarestani, M., Pirhayati, M., Zendehdel, A., Manafi, N.,Hajiabdolbaghi, M., Ahmadinejad, Z., Kouchak, H. E., Jafari, S., Khalili, H., Salehi, M., Seifi, A., Golestan, F. S., & Ghiasvand, F. (2020). Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial. InternationalJournal of Antimicrobial Agents, 56, 7. https://doi.org/10.1016/j.ijantimicag.2020.106143
Shen, C., Yue, X., Wang, J., Shi, C., & Li, W. (2020). Nocturnal oxygen therapy as an option for early COVID-19. International Journal of Infectious Diseases, 98, 176-179. https://doi.org/10.1016/j.ijid.2020.06.080
Published
How to Cite
-
Abstract424
-
PDF (Español (España))104
-
HTML (Español (España))10
Issue
Section
License
Copyright (c) 2021 Yda F Camposano, Raúl Ureta Jurado, Lady Camposano, Paula MC Gutiérrez
This work is licensed under a Creative Commons Attribution 4.0 International License.
